Audited Results of Strides Pharma Science Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	2,180.14	2,139.42	2,153.26	1,854.50	1,979
Manufacturing Expenses	32.96	36	53.12	45.54	43.76
Personnel Expenses	381.60	377.59	335.21	267.01	272.09
Selling Expenses	0	0	0	0	0
Administrative Expenses	323.95	338.65	359.41	344.06	438.34
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,895.09	1,876.98	1,897.98	1,756.02	1,902.37
Operating Profit	285.04	262.44	255.28	98.48	76.63
Other Recurring Income	123.06	46.19	72.31	84.07	123.48
Adjusted PBDIT	408.11	308.63	327.58	182.54	200.12
Financial Expenses	113.77	145.91	167.93	138.68	74.24
Depreciation	91.24	84.61	84.67	93.62	104.37
Other Write offs	0	0	0	0	0
Adjusted PBT	203.10	78.11	74.99	-49.76	21.51
Tax Charges	19.47	18.93	4.13	-69.44	-158.68
Adjusted PAT	183.63	59.18	70.86	19.68	180.19
Non Recurring Items	0	2,827.03	-5.37	-15	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	183.63	2,886.21	65.49	4.68	180.19
Equity Dividend	36.87	22.99	13.55	0	0
Preference Dividend	0	0	0	0	0
Retained Earnings	902.32	3,582.61	797.51	745.57	763.32

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article